Radiation before chemoimmunotherapy may boost lung cancer surgery success

NCT ID NCT06800339

First seen May 12, 2026 · Last updated May 15, 2026 · Updated 1 time

Summary

This early-phase study is testing whether giving a short course of high-dose radiation before standard chemotherapy and immunotherapy can help shrink borderline resectable non-small cell lung cancer enough to allow successful surgery. About 18 adults with stage II to IIIC lung cancer will receive three doses of radiation, followed by up to three cycles of chemo plus nivolumab, then surgery. The main goal is to see if this combination is safe and tolerable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baltimore Washington Medical Center- Tate Cancer Center

    RECRUITING

    Glen Burnie, Maryland, 21061, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Maryland Proton Treatment Center

    RECRUITING

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Maryland Greenebaum Cancer Center

    RECRUITING

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Upper Chesapeake- Kaufman Cancer Center

    RECRUITING

    Bel Air, Maryland, 21014, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.